General info
How to Talk with Your Doctor About Your Child's Type 1 Diabetes Screening Results
As a parent with Type 1 diabetes, you know firsthand what it's like to manage this condition. When your child gets screened for T1D risk, understanding and discussing those results with your doctor can feel overwhelming. This guide will help you navigate these important conversations with confidence.
Understanding What You're Looking At
When your child is screened for Type 1 diabetes risk, doctors test for autoantibodies—proteins that signal the immune system is attacking insulin-producing cells. Your child might hear about tests for:
- GAD (Glutamic Acid Decarboxylase autoantibody)
- IAA (Insulin Autoantibody)
- IA-2 (Insulinoma Antigen-2 autoantibody)
- ZnT8 (Zinc Transporter 8 autoantibody)
The number and type of autoantibodies help determine your child's risk level and monitoring plan.
[ image place ]
Essential Questions to Ask Your Doctor
About the Test Results
"How many autoantibodies does my child have, and which ones?"
- This determines risk level and monitoring frequency
- Multiple autoantibodies mean higher risk
"What stage is my child in?"
- Stage 1: Multiple autoantibodies, normal blood sugar, no symptoms
- Stage 2: Multiple autoantibodies, blood sugar changes, no symptoms
- Stage 3: Clinical Type 1 diabetes with symptoms
"What are my child's current blood sugar levels?"
- Ask for specific numbers (fasting glucose, HbA1c, OGTT results if done)
- Understand what these numbers mean for your child's stage
About Monitoring and Next Steps
"How often should we come back for monitoring?"
- One autoantibody: Every 6-12 months
- Multiple autoantibodies: Every 3-12 months (varies by age)
- Young children (under 3) with positive results may need 3-6 month checks
"What symptoms should I watch for at home?"
- Classic symptoms: increased thirst, frequent urination, weight loss, fatigue
- When to call immediately vs. wait for next appointment
"Are there any clinical trials or early intervention options available?"
- Some treatments can delay progression to Stage 3
- Ask about eligibility for research studies
About Your Family
"Should my other children be screened?"
- Siblings of people with T1D have 15x higher risk
- Discuss timing and frequency for other family members
"How is my child's risk different because I have Type 1 diabetes?"
- Your experience can be both helpful and emotionally challenging
- Ask about family support resources
[ image place ]
Tips for Productive Conversations
Before Your Appointment:
- Write down your questions ahead of time
- Bring a notebook or use your phone to take notes
- Consider bringing a support person who can help you remember details
During Your Appointment:
- Ask your doctor to explain anything you don't understand
- Request specific numbers, not just "normal" or "high"
- Don't hesitate to ask questions—no question is too small
After Your Appointment:
- Summarize what you learned and confirm next steps
- Ask for written information or resources to take home
- Get clear contact information for questions between visits
Remember: Knowledge is Power
Finding out your child has autoantibodies doesn't mean they'll definitely develop Type 1 diabetes, and it certainly doesn't mean you've done anything wrong. As research advances, early detection gives you and your medical team the best opportunity to:
- Prevent dangerous diabetic ketoacidosis (DKA) at diagnosis
- Access emerging therapies that may delay progression
- Prepare emotionally and practically as a family
- Make informed decisions about your child's health
Your experience living with T1D makes you uniquely positioned to recognize symptoms early and advocate for your child. Trust your instincts, ask questions, and remember that you're part of a medical team working together for your child's health.
References
- American Diabetes Association. (2026). Standards of Care in Diabetes—2026. Diabetes Care.
https://professional.diabetes.org/standards-of-care - Wherrett, D. K., et al. (2024). Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes. Diabetes Care, 47(8), 1276-1298.
https://diabetesjournals.org/care/article/47/8/1276/156880/ - Breakthrough T1D. (2024). Type 1 Diabetes Screening & Early Detection.
https://www.breakthrought1d.org/early-detection/ - Type 1 Diabetes TrialNet. Pathway to Prevention: Risk Screening.
https://www.trialnet.org/our-research/risk-screening
